Comprehensive dosage monitoring of topical treatments for mild to moderate psoriasis.
Deepak Sirdeshmukh, MS, PhD
Advertisement
Co-founder, President, and CEO of Sensal Health
Articles by Deepak Sirdeshmukh, MS, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Amgen’s Tarlatamab Approved in China
2
Pharmaceutical Executive Daily: China Approves Amgen's Tarlatamab for Previously Treated Extensive-Stage Small Cell Lung Cancer
3
Roche and C4 Therapeutics Expands Partnership with $1 Billion Collaboration Agreement
4
Shionogi Inc. Awarded $482 Million Contract with U.S. Government to Enhance National Preparedness for Drug-Resistant Bacterial Threats
5